Workplace HealthH@WNCT00858533
Trial of Health At Work Workplace Health Intervention
A study testing Health at Work workplace health advice and support in people with Workplace Health, run by University of Liverpool at 1 site in United Kingdom.
Trial summary
This pilot study will compare workplace health intervention delivered by advisors based in GP practices with normal GP care to assess the usefulness of the concept and its potential for wider use in a larger randomised controlled trial. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Workplace Health
- What is being tested?
- Health at Work workplace health advice and support
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 63 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- Jun 2008to Mar 2010
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- People with work related health problems registered with GP practices in Liverpool Primary Care Trust.
Who cannot join
- People registered with GP practices outside Liverpool Primary Care Trust.
- Vulnerable adults and those considered by their GP to be unsuitable for the trial.
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site
Division of Primary Care, University of Liverpool.
Liverpool, Merseyside, L69 3GB
About this study
Official title: A Pilot Controlled Feasibility Trial of Early Health At Work Workplace Intervention
This pilot study will compare workplace health intervention delivered by advisors based in GP practices with normal GP care to assess the usefulness of the concept and its potential for wider use in a larger randomised controlled trial.
Read the detailed description
The aim of this pilot study is to examine the impact of H@W intervention(s) on job retention and return to work and compare outcomes with those from normal GP care. The target population for this study is people still at work but experiencing a work-related health problem as well as those off work. For the purpose of the study, short term sickness absence is defined as a period of 4 weeks or less and long term sickness absence defined as a period of 4 weeks or longer. Hypothesis
That H@W intervention in comparison to standard care:
- promotes work retention
- enables a quick and sustained return to work for those on short term sick leave (4 weeks or less)
- achieves sustained return to work for those on long term sick leave of 4 weeks or more. This could include a phased return to work.
- achieves positive outcomes which could mean leaving one job and starting another.
- Conditions
- Workplace Health
- Being tested
- Health at Work workplace health advice and support
- Keywords
- early intervention, sickness absence, return to work, primary care
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Health at Work workplace health advice and supportBehavioural
The intervention group will receive additional support from a H@W Workplace Health Advisor who will deliver an intervention aimed at sickness absence prevention or sustained return to work, depending on individual circumstances. The intervention will be standardized as far as possible to show types of activity undertaken with participants, their GP, line managers, human resources departments and trade union representatives.
| Study group | Role | What they receive |
|---|---|---|
| workplace health advice | Other | The intervention group will receive additional support from a H@W Workplace Health Advisor who will deliver an intervention aimed at sickness absence prevention or sustained return to work, depending on individual circumstances. Receives: Behavioral: Health at Work workplace health advice and support |
| GP sickness absence consultation | No intervention | Routine general practitioner care for workplace sickness absence. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of days off work through sickness absence after index consultation, which will also apply to people at work with a work-relevant condition
Measured: 1 year
Secondary outcomes (1)
Secondary outcome measure: time to first return to work (RTW) allowing for phased return.
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Mar 2009 (estimated)
- Study startJun 2008
- Primary completionMar 2010
- Study completionMar 2010
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Workplace HealthStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 63 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Liverpool
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Mark B Gabbay, MD, Principal investigator, University of Liverpool
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00858533
- Sponsor's protocol ID
- BER10457
- Acronym
- H@W
- Status last verified
- Jan 2010
- First submitted
- 9 Mar 2009
- Last updated
- 30 Oct 2024
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 30 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Pilot Controlled Feasibility Trial of Early Health At Work Workplace Intervention
- ClinicalTrials.gov ID
- NCT00858533
- Acronym / sponsor ID
- H@W / BER10457
- Conditions
- Workplace Health
- Keywords
- early intervention, sickness absence, return to work, primary care
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 63 participants (actual)
- Lead sponsor
- University of LiverpoolUniversity, hospital or other
- Study start
- Jun 2008
- Primary completion
- Mar 2010 (actual)
- Study completion
- Mar 2010 (actual)
- First posted
- 10 Mar 2009 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This pilot study will compare workplace health intervention delivered by advisors based in GP practices with normal GP care to assess the usefulness of the concept and its potential for wider use in a larger randomised controlled trial.
Detailed description
The aim of this pilot study is to examine the impact of H@W intervention(s) on job retention and return to work and compare outcomes with those from normal GP care. The target population for this study is people still at work but experiencing a work-related health problem as well as those off work. For the purpose of the study, short term sickness absence is defined as a period of 4 weeks or less and long term sickness absence defined as a period of 4 weeks or longer. Hypothesis
That H@W intervention in comparison to standard care:
- promotes work retention
- enables a quick and sustained return to work for those on short term sick leave (4 weeks or less)
- achieves sustained return to work for those on long term sick leave of 4 weeks or more. This could include a phased return to work.
- achieves positive outcomes which could mean leaving one job and starting another.
Study design
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| workplace health advice | Other | Behavioral: Health at Work workplace health advice and supportThe intervention group will receive additional support from a H@W Workplace Health Advisor who will deliver an intervention aimed at sickness absence prevention or sustained return to work, depending on individual circumstances. |
| GP sickness absence consultation | No intervention | –Routine general practitioner care for workplace sickness absence. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- People with work related health problems registered with GP practices in Liverpool Primary Care Trust.
Key exclusion criteria (2 listed)
- People registered with GP practices outside Liverpool Primary Care Trust.
- Vulnerable adults and those considered by their GP to be unsuitable for the trial.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Health at Work workplace health advice and supportThe intervention group will receive additional support from a H@W Workplace Health Advisor who will deliver an intervention aimed at sickness absence prevention or sustained return to work, depending on individual circumstances. The intervention will be standardized as far as possible to show types of activity undertaken with participants, their GP, line managers, human resources departments and trade union representatives. | Behavioural | workplace health advice |
Primary outcome
Number of days off work through sickness absence after index consultation, which will also apply to people at work with a work-relevant condition
Time frame: 1 year
1 secondary outcome
Secondary outcome measure: time to first return to work (RTW) allowing for phased return.
Time frame: 1 year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Oct 2024.
Related trials for Workplace Health
Active, not recruiting
Online Mindfulness-Based Stress Reduction for the Mental Health of Healthcare Professionals
Occupational Stress or Workplace Stress, Burnout, Professionals
Not yet recruiting
Mobile-Based Resilience Intervention for Moral Injury, Compassion Fatigue, and Distress in ICU Nurses
Moral Injury
Recruiting
NUS Health Study: Improving Sleep, Sedentariness and Physical Activity in NUS Staff
Focused Strategies to Optimize Sleep, Reduce Sedentary Behaviour, and Enhance Incidental Physical Activity
Recruiting
Exercise and Health Education for Musculoskeletal Health in Industrial Workers
Work-Related Musculoskeletal Disorders
Enrolling by invitation
Online Socio-emotional Dyad Training for School Teachers' Well-being and Social Skills
Intervention (Training) Condition, Waitlist Control Group
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mark B Gabbay, MD principal investigator
University of Liverpool
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Health at Work workplace health advice and support in people with Workplace Health, run by University of Liverpool at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of days off work through sickness absence after index consultation, which will also apply to people at work with a work-relevant condition (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Oct 2024.